Genome-wide analysis of temporomandibular disorders in FinnGen: cross-population replication and genetic overlap with chronic pain
This genome-wide analysis of Temporomandibular Disorders (TMD) in FinnGen identifies two significant genetic loci, confirms high genetic correlation with US European-ancestry populations, and reveals that TMD shares stronger genetic links with chronic pain, psychiatric conditions, and insomnia than with joint diseases.
Original paper licensed under CC BY 4.0 (https://creativecommons.org/licenses/by/4.0/). This is an AI-generated explanation of a preprint that has not been peer-reviewed. It is not medical advice. Do not make health decisions based on this content. Read full disclaimer
Temporomandibular disorders, often called TMD, are a collection of painful conditions affecting the jaw joint and the muscles used for chewing. For millions of people, these issues are the most common source of chronic pain in the face that does not originate from a toothache. While the exact cause remains complex, doctors have long observed that TMD rarely travels alone. It frequently appears alongside other conditions like chronic headaches, back pain, sleeplessness, and anxiety. This clustering suggests that the body's pain processing system might be involved, rather than just a mechanical problem with the jaw itself. Scientists have also known for some time that these disorders run in families, hinting that our genes play a significant role in who develops them. However, until recently, the genetic clues were scattered and difficult to piece together, leaving a gap in our understanding of whether these genetic risks are specific to certain populations or shared across the world, and how closely they are tied to the broader experience of chronic pain versus simple joint wear and tear.
A team of researchers set out to fill these gaps by conducting a massive genetic scan of nearly 23,000 people with TMD from a large Finnish database, comparing their genetic makeup against hundreds of thousands of people without the condition. By looking at millions of tiny variations in DNA across the entire genome, they were able to identify specific locations in our genetic code that influence the risk of developing jaw pain. The study confirmed that the genetic factors driving TMD in Finland are largely the same as those found in European populations in the United States, suggesting that the biological roots of this condition are shared across these groups. More importantly, the researchers found that the genetic signature of TMD aligns much more closely with a cluster of chronic pain, sleep disturbances, and mood disorders than it does with typical joint diseases like arthritis. This distinction is crucial because it shifts the focus from viewing TMD solely as a mechanical failure of the jaw to understanding it as part of a broader, body-wide sensitivity to pain.
The analysis pinpointed two specific regions in the human genome that showed a strong, statistically significant link to TMD. One of these regions, located on chromosome 7, contains several genes that are involved in how cells communicate and how the immune system functions. The other region, on chromosome 12, involves a gene called SYT1, which plays a key role in how nerve cells release chemical signals. The researchers noticed something unusual about the second region: the genetic variant that appears to protect against TMD is about seven times more common in the Finnish population than in other European groups. This rarity in the rest of the world made it difficult to confirm the finding in other large groups of people, though the initial signal was strong enough to warrant further investigation. While the study identified these genetic hotspots, it could not yet definitively say which specific gene within those regions is the primary driver of the pain, nor could it prove that the genes work by changing how much of a specific protein is made in the body.
Perhaps the most revealing part of the study was how the genetic risk for TMD compared to other health conditions. The researchers measured the genetic overlap between TMD and fifteen different traits, ranging from digestive issues to joint inflammation. They found that the genetic risk for TMD was strongly linked to irritable bowel syndrome, headaches, insomnia, fibromyalgia, and depression. In fact, the connection to these pain and mood-related conditions was far stronger than the connection to rheumatoid arthritis or osteoarthritis, which are diseases of the joints themselves. This pattern supports the idea that TMD is part of a "chronic overlapping pain" syndrome, where the central nervous system becomes hypersensitive, causing pain to be felt in multiple areas of the body simultaneously. The study also found a weaker, but still present, link to osteoarthritis, suggesting that while some wear and tear of the jaw joint might contribute to the problem, the primary driver appears to be this shared sensitivity to pain and stress.
Despite these clear genetic connections, the study also highlighted the complexity of translating these findings into immediate medical solutions. The researchers used advanced statistical methods to look for evidence that the identified genes were directly causing changes in the activity of other genes in specific tissues, such as the brain or muscles, but they did not find strong proof of this mechanism. This means that while we now know where in the DNA the risk lies, the exact how remains a mystery. The study also noted that the genetic data came from medical records rather than direct physical examinations, which means some people might have been misclassified, and the findings are based on populations of European ancestry, leaving questions about how these genetic risks apply to people of other backgrounds. Nevertheless, the work provides a solid biological foundation for the clinical observation that patients with jaw pain often suffer from other chronic conditions, reinforcing the need for doctors to look at the whole person rather than just the jaw when treating these disorders.
Drowning in papers in your field?
Get daily digests of the most novel papers matching your research keywords — with technical summaries, in your language.